Vinicio Fosser
About
In The Last Decade
Vinicio Fosser
27 papers receiving 530 citations
Peers
Comparison fields: 5 of 69
- Oncology 298
- Pulmonary and Respiratory Medicine 251
- Surgery 104
- Genetics 94
- Cardiology and Cardiovascular Medicine 89
Countries citing papers authored by Vinicio Fosser
This map shows the geographic impact of Vinicio Fosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinicio Fosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinicio Fosser more than expected).
Fields of papers citing papers by Vinicio Fosser
This network shows the impact of papers produced by Vinicio Fosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinicio Fosser. The network helps show where Vinicio Fosser may publish in the future.
Co-authorship network of co-authors of Vinicio Fosser
This figure shows the co-authorship network connecting the top 25 collaborators of Vinicio Fosser. A scholar is included among the top collaborators of Vinicio Fosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinicio Fosser. Vinicio Fosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 119 | |
| 4 | 1 | |
| 5 | 181 | |
| 6 | Hepatic arterial infusion (HAI) of high dose chemotherapy plus caval chemofiltration vs HAI of prolonged low doses in patients with liver matastases from colorectal carcinoma: Result of a prospective randomized trial. | 3 |
| 7 | 18 | |
| 8 | 22 | |
| 9 | 7 | |
| 10 | Oral ondansetron (GR38032F) for the control of acute and delayed cyclophosphamide-induced emesis. | 14 |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 10 | |
| 15 | 17 | |
| 16 | 9 | |
| 17 | 22 | |
| 18 | 2 | |
| 19 | 3 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.